Dr. Sayan Sinha Roy

Dr. Sayan Sinha Roy Clinical Hematology and Bone Marrow Transplantation

Dr. Sayan Sinha Roy

Clinical Hematologist and Bone Marrow Transplantat Physician

Clinical Hematology and Bone Transplant Physician MD (Internal Medicine), DM (Clinical Hematology)

Expertise : Clinical Hematology & Bone Marrow Transplant


Dr. Sayan Sinha Roy is a Clinical Hematologist, Hemato Oncologist, and Bone Marrow Transplant (BMT) Physician at the Mahatma Gandhi Cancer Hospital & Research Institute, Visakhapatnam. 


    Area(s) of Interest

    • Myeloid Neoplasm
    • Acute Lymphoblastic Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
    • Myeloma
    • Lymphoma
    • Bone Marrow Failure Syndromes
    • Platelet Disorders


    • High-Volume Bone Marrow Transplant
    • Car T Cell (CD 19 CART) Therapy

    Education & Training

    Name of Institute(s)

    • DM (Clinical Hematology) from PGIMER, Chandigarh
    • MD (Internal Medicine) from PGIMER, Dr. R.M.L Hospital, New Delhi
    • MBBS from Calcutta National Medical College and Hospital, Kolkata

    Professional Highlights


      • Saini M, Khadwal A R, Roy S S, et al. (September 13, 2023) Haploidentical Transplant in Radiosensitive Severe Combined Immunodeficiency Disease. Cureus 15(9):e45159. Doi:10.7759/cureus.45159
      • Gupta S, Sinha Roy S, Jain A, Lad D, Malhotra P. A young patient presented with inflammatory gingival overgrowth. Oral Dis. 2023;29(5):1891-1893

      Paper Presentations and Research Papers:

      • Presented (oral presentation) research on post-transplant micro vasculopathy at the 27th Asia Pacific Blood and Marrow Transplant (APBMT) Conference 2022 in Kochi
      • Presented research at the 27th Asia Pacific Blood and Marrow Transplant (APBMT) Conference 2022 in Kochi
      • 49th European Bone Marrow Transplant (EBMT) Conference 2023 in Paris
      • During MD in General Medicine, completed a thesis on “Comparison of Framingham risk score, QRISK2, and ACC/AHA 2013 risk score in predicting cardiovascular risk in patients with rheumatoid arthritis.”
      • During DM in Clinical Hematology, completed a thesis on “A prospective cohort study to evaluate endothelial dysfunction by using non-invasive tests of endothelial function in hematopoietic stem cell transplant recipients.”